Healthcare provider profile · identity verified

Holly A Hett, MD

Family Practice · APPLE VALLEY, MN · NPI 1053358911

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	158
Levothyroxine Sodium	Levothyroxine Sodium	451	121
Losartan Potassium	Losartan Potassium	329	90
Lisinopril	Lisinopril	306	90
Amlodipine Besylate	Amlodipine Besylate	267	69
Simvastatin	Simvastatin	233	63
Omeprazole	Omeprazole	230	67
Rosuvastatin Calcium	Rosuvastatin Calcium	218	64
Hydrochlorothiazide	Hydrochlorothiazide	154	43
Escitalopram Oxalate	Escitalopram Oxalate	147	45
Gabapentin	Gabapentin	131	36
Metoprolol Succinate	Metoprolol Succinate	131	37
Metformin Hcl	Metformin Hcl	127	38
Trazodone Hcl	Trazodone Hcl	111	32
Pantoprazole Sodium	Pantoprazole Sodium	103	32
Famotidine	Famotidine	97	35
Fluoxetine Hcl	Fluoxetine Hcl	94	25
Sertraline Hcl	Sertraline Hcl	93	25
Atenolol	Atenolol	88	23
Furosemide	Furosemide	88	27
Pravastatin Sodium	Pravastatin Sodium	88	20
Warfarin Sodium	Warfarin Sodium	88	21
Alendronate Sodium	Alendronate Sodium	85	28
Metformin Hcl Er	Metformin Hcl	83	24
Eliquis	Apixaban	82	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	19
Bupropion Xl	Bupropion Hcl	67	19
Carvedilol	Carvedilol	57	15
Albuterol Sulfate Hfa	Albuterol Sulfate	53	25
Fluticasone Propionate	Fluticasone Propionate	51	21
Glipizide Er	Glipizide	49	12
Metoprolol Tartrate	Metoprolol Tartrate	49	14
Allopurinol	Allopurinol	48	14
Zolpidem Tartrate	Zolpidem Tartrate	48	12
Ozempic	Semaglutide	46	suppressed
Synthroid	Levothyroxine Sodium	46	11
Montelukast Sodium	Montelukast Sodium	44	11
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Chlorthalidone	Chlorthalidone	36	11
Trulicity	Dulaglutide	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Potassium Chloride	Potassium Chloride	31	11
Xarelto	Rivaroxaban	31	suppressed
Ezetimibe	Ezetimibe	30	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Cephalexin	Cephalexin	28	23
Estradiol	Estradiol	28	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	suppressed
Prednisone	Prednisone	25	16
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Amoxicillin	Amoxicillin	20	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glipizide	Glipizide	15	suppressed
Potassium Citrate Er	Potassium Citrate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	12
Verapamil Er	Verapamil Hcl	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error